Erratum to Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study [Arch Gynecol Obstet, (2015), 292, (1163-1171), DOI 10.1007/s00404-015-3747-5]

Simple item page
dc.contributor.authorTuran G.A.
dc.contributor.authorEskicioglu F.
dc.contributor.authorSivrikoz O.N.
dc.contributor.authorCengiz H.
dc.contributor.authorAdakan S.
dc.contributor.authorGur E.B.
dc.contributor.authorTatar S.
dc.contributor.authorSahin N.
dc.contributor.authorYilmaz O.
dc.date.accessioned2024-07-22T08:12:04Z
dc.date.available2024-07-22T08:12:04Z
dc.date.issued2016
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1007/s00404-016-4021-1
dc.identifier.issn09320067
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/15884
dc.language.isoEnglish
dc.publisherSpringer Verlag
dc.rightsAll Open Access; Bronze Open Access; Green Open Access
dc.subjectErratum
dc.subjecterror
dc.titleErratum to Myo-inositol is a promising treatment for the prevention of ovarian hyperstimulation syndrome (OHSS): an animal study [Arch Gynecol Obstet, (2015), 292, (1163-1171), DOI 10.1007/s00404-015-3747-5]
dc.typeErratum

Files

Collections

Scopus Koleksiyonu